LINC02310

Across TCGA pan-cancer cohorts, LINC02310 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC02310 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02310 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02310 expression acts as an unfavorable survival marker, although some lineages such as KIRC and ESCA show a favorable association.

ACC, KICH, and LUAD are the cancer types where LINC02310 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	II,III,IV	0.189	0.650	<.001	96	view →
KICH	DFS	Tertile	All	0.385	0.885	<.001	93	view →
LUAD	OS	Tertile	All	0.199	0.398	<.001	64	view →
STAD	DFS	Quartile	II,III,IV	0.388	0.584	<.001	63	view →
LIHC	DFS	Tertile	All	0.237	0.457	<.001	39	view →
KIRC	OS	Tertile	All	0.723	0.511	<.001	37	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
READ	OS	Tertile	II,III,IV	0.193	0.675	.003	30	view →
ESCA	OS	Median	All	1.000	0.474	.021	29	view →
KIRP	DFS	Median	IV	0.594	0.038	.004	24	view →
BRCA	DFS	Tertile	All	0.685	0.489	.012	18	view →
SKCM	OS	Tertile	IV	0.213	0.775	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC02310–ACC (DFS)

Open the ACC breakdown →